Consultation meeting regarding strategies to increase hepatitis C (HCV) treatment within ADAPs. Report features:
- Participants in the consultation
- Best practices in ADAP HCV treatment utilization
- Round-robin discussions
- Recommendations
- Summary tables of ADAP formulary inclusion of directly-acting antiviral (DAA) HCV medications and coverage policies